Breadcrumb

  1. Insights
  2. Alerts

Alerts

5255 total results. Page 1 of 211.

D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Heather M. Zimmer, Elizabeth McLaughlin

Headlines that Matter for Companies and Executives in Regulated Industries

Katia Asche, Jay M. Thomas

As noted in a recent article in The New York Times, generative artificial intelligence (AI) tools are fundamentally transforming the landscape of pro se litigation.

David P. Grosso, Jon S. Bouker

On June 16, the District of Columbia held its primary election — the first conducted under the District’s new ranked-choice voting (RCV) system.

Patricia A. Pileggi, Brittany H. Sokoloff, Sean A. Worley

For thousands of federal prisoners who received lengthy mandatory sentences under laws that US Congress has since reformed, compassionate release offered a potential path to relief. But on May 28, the US Supreme Court significantly narrowed that path.

Linda M. Jackson, Matthew F. Prewitt, Allan E. Anderson, Nicholas J. Nesgos, Alexander H. Spiegler, Nicole Curtis Martinez, James D. Cromley

The Federal Circuit held that the district court erred by precluding plaintiffs from pursuing unjust enrichment damages for trade secret misappropriation claims.

Matthew Berlin, Danielle W. Bulger, Cissy Jackson, Emily B. Lewis, Natasha Weis, Nardeen Billan, Perry A. Jackson

On June 4, US Representatives Jay Obernolte (R-Calif.) and Lori Trahan (D-Mass.) released a discussion draft of the bipartisan Great American AI Act of 2026 (GAAIA), which would establish a framework regulating artificial intelligence (AI) at the federal level.

D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Heather M. Zimmer, James G. Pizzo

Headlines that Matter for Companies and Executives in Regulated Industries

Taniel E. Anderson, Michael J. Baldwin

Ex parte reexamination has recently overtaken inter partes reviews (IPRs) in terms of popularity. Petitions for IPRs have fallen dramatically since late 2025, with only 15 petitions filed in April of this year.

Emily M. Cowley, Shoshana Golden

On June 10, the US Food and Drug Administration (FDA) issued a final administrative order adding bemotrizinol to the list of permissible sunscreen active ingredients in the United States – the first new sunscreen active added in 26 years.

Andrew Baskin, Robert K. Carrol

The US House of Representatives has passed the Faster Labor Contracts Act (H.R. 5408) (FLCA), a bill that would fundamentally reshape how employers negotiate first collective bargaining agreements with newly certified unions.

Emily M. Cowley, Abha Kundi

On June 2, the US Food and Drug Administration (FDA) released a new draft guidance called “Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing.”

Sarah L. Lode, J. Michael Showalter, Robert A.H. Middleton

State policymakers are recalibrating how they regulate and incentivize data center development.

Katia Asche, Lynn R. Fiorentino, Sean A. Worley

Earlier this year, we flagged the growing momentum behind state efforts to regulate dynamic and surveillance pricing.

Robert A.H. Middleton, Amy Antoniolli, Sarah L. Lode, Meera Gorjala, Duncan M. Weinstein

The Federal Aviation Administration (FAA) and US Department of Defense have stalled project reviews.

David P. Grosso, Anisa Ostad

The 2027 DC budget would deliver significant new funding, programs, and policy changes to rental housing across the District of Columbia, affecting all parties involved, like tenants, landlords, and developers.

Gayland O. Hethcoat II

On June 8, the California State Senate adopted Senate Resolution (SR) 104, a measure expressing support for targeting the biological mechanisms of aging as a strategy to prevent and delay chronic disease.

Nicholas J. Nesgos, Lynn R. Fiorentino, Benjamin M. Greene, Taylor Listau , Bryn Doyle

On May 28, the US Supreme Court issued a unanimous decision in Flowers Foods, Inc. v. Brock, holding that a worker who transports goods on an intrastate leg of an interstate journey may qualify for the Federal Arbitration Act’s (FAA) transportation-worker exemption under Section 1 — even if that worker never crosses state lines and never interacts with a vehicle that does.

Angela M. Santos, Nichole D. Shustack, Isabelle R. Cunningham

US alcohol importers, and alcohol suppliers that rely on imported ingredients or raw materials to produce their products, have been on a rollercoaster during President Trump’s second term trying to keep up with the Administration’s tariff policy.

David P. Grosso, Douglas A. Grimm

The 2027 DC budget proposes substantial investments in health care access, behavioral health services, and public health infrastructure across the District of Columbia. Nearly four in 10 DC residents depend on Medicaid, the Basic Health Plan, or the locally funded Alliance program for coverage.

Abha Kundi, Emily M. Cowley, Shoshana Golden

On June 3, the US Food and Drug Administration (FDA) released a revised draft guidance on what drug and device manufacturers can say to health insurers, pharmacy benefit managers (PBMs), formulary committees, and similar organizations about their products.

David P. Grosso, Jon S. Bouker

The 2027 DC budget would make sweeping investments in education across the District of Columbia, from pre-kindergarten through higher education and adult literacy. The budget supports nearly 100,000 public and public charter school students, increases per-student funding, restores critical childcare programs at risk of deep cuts, and expands career and technical education.

D. Reed Freeman Jr., Michelle R. Bowling, Andrea M. Gumushian, Perry A. Jackson , John M. Keblish

The 2026 legislative cycle reveals that state privacy law is diverging along partisan lines. Red-state legislatures are pursuing frameworks that retain the Virginia architecture while easing compliance burdens through broader exemptions, narrower sale definitions, permanent cure periods, and fewer assessment requirements. Blue states are moving in the opposite direction, expanding sensitive-data categories, imposing new technology-specific obligations, and broadening applicability.

Sailesh K. Patel, Justine E.F. May

On June 4, the US Supreme Court issued a unanimous decision authored by Justice Ketanji Brown Jackson in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24–889, delivering a significant win for generic pharmaceutical manufacturers seeking US Food and Drug Administration (FDA) approval for drugs with multiple indications.

Cissy Jackson, Matthew Berlin, Nardeen Billan, Natasha Weis, Perry A. Jackson

On June 2, President Trump signed an executive order (EO) entitled “Promoting Advanced Artificial Intelligence Innovation and Security” that establishes new federal cybersecurity directives, creates a voluntary framework for collaboration with artificial intelligence (AI) developers on frontier models, and signals increased focus on criminal enforcement against AI-enabled cyberattacks. 

Robert A.H. Middleton, Amy Antoniolli, Sarah L. Lode, Meera Gorjala, Duncan M. Weinstein

The Fourth Appellate District’s June 2 decision in Tate Road Solar 1, LLC v. County of Winnebago held that Illinois courts cannot compel counties to issue permits when solar projects meet statewide standards for solar siting under 55 ILCS 5/5-12020.